New England BioLabs, Inc.

États‑Unis d’Amérique

Retour au propriétaire

1-100 de 460 pour New England BioLabs, Inc. Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 306
        Marque 154
Juridiction
        États-Unis 292
        International 137
        Canada 30
        Europe 1
Date
Nouveautés (dernières 4 semaines) 3
2024 avril (MACJ) 1
2024 mars 2
2023 décembre 5
2024 (AACJ) 4
Voir plus
Classe IPC
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des acides nucléiques 97
C12N 9/22 - Ribonucléases 70
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN 68
C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7) 59
C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides 56
Voir plus
Classe NICE
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 134
42 - Services scientifiques, technologiques et industriels, recherche et conception 31
09 - Appareils et instruments scientifiques et électriques 18
05 - Produits pharmaceutiques, vétérinaires et hygièniques 15
35 - Publicité; Affaires commerciales 13
Voir plus
Statut
En Instance 60
Enregistré / En vigueur 400
  1     2     3     ...     5        Prochaine page

1.

TRICAP

      
Numéro de série 98484578
Statut En instance
Date de dépôt 2024-04-04
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Nucleic acid products, namely, mRNA and mRNA capping reagents for scientific research Nucleic acid products, namely, mRNA and mRNA capping reagents for pharmaceutical purposes and medical purposes

2.

FUSER

      
Numéro de série 98472886
Statut En instance
Date de dépôt 2024-03-28
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Reagents for scientific and research use for molecular biology and cell biology applications; Enzymes for scientific and research use for molecular biology and cell biology applications; Reagents for scientific and research use for use in sequencing applications; Enzymes for scientific and research use for use in sequencing applications; Kits for use in sequencing applications comprised of reagents and enzymes for scientific use; Chemicals for use in industry and science; DNA polymerase, reagents and reagent kits comprising generic DNA circle, DNA polymerase and buffers for scientific, medical or veterinary research use; DNA polymerase, reagents and reagent kits comprising generic DNA circle, DNA primers, DNA polymerase and buffers for use in the biotechnology field

3.

METHODS FOR CHARACTERIZING AN IMMUNE RESPONSE REPERTOIRE

      
Numéro d'application US2023074661
Numéro de publication 2024/064736
Statut Délivré - en vigueur
Date de dépôt 2023-09-20
Date de publication 2024-03-28
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Song, Chen
  • Erijman, Ariel
  • Lund, Sean
  • Langhorst, Bradley, W.
  • Liu, Pingfang

Abrégé

This disclosure provides synthetic nucleic acid oligonucleotides and related methods for analysis of immune repertoires. A disclosed synthetic oligonucleotide contains (a) one or more tags with a sequence that is not contained in a eukaryotic immune repertoire, wherein at least one tag is positioned between a region corresponding to a diversity and joining region (( D)J) and a constant region (C) of an immunoglobulin (IG) or T cell receptor, thereby distinguishing the synthetic oligonucleotide from naturally occurring sequences in the eukaryotic immune repertoire; and wherein the V(D)J region has a predetermined V(D)J clonotype, the synthetic oligonucleotide optionally further comprising a tag proximate to a region corresponding to a eukaryotic variable region (V); and optionally wherein C further comprises one or more priming sites for nucleic acid amplification.

Classes IPC  ?

  • C12Q 1/6851 - Amplification quantitative
  • C12Q 1/6881 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p.ex. amorces ou sondes pour le typage de tissu ou de cellule, p.ex. sondes d’antigène leucocytaire humain [HLA]

4.

NEW ENGLAND BIOLABS MONARCH DNA & RNA PURIFICATION

      
Numéro de série 98427591
Statut En instance
Date de dépôt 2024-02-29
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Biological and biochemical reagents or kits for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; chemical products for commercial and scientific purposes, namely, chemicals or biochemicals for the isolation and purification of nucleic acids for scientific purposes and for use in polymerase chain reaction; all sold either individually or in kits

5.

LYOPRIME

      
Numéro d'application 1768708
Statut Enregistrée
Date de dépôt 2023-11-06
Date d'enregistrement 2023-11-06
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific research use; reagents for molecular biology and/or cell biology for scientific, research, laboratory or in vitro diagnostic use; reagents for diagnostic tests and/or diagnostic devices for scientific, research, laboratory or in vitro diagnostic use; reagents for genetic research, clinical or medical laboratory use; enzyme reagents for scientific, research, laboratory or in vitro diagnostic use; enzymes for scientific and/or research use; enzymes for molecular biology research and/or cell biology scientific and research applications.

6.

Vaccinia Capping Enzyme Compositions and Methods

      
Numéro d'application 18462868
Statut En instance
Date de dépôt 2023-09-07
Date de la première publication 2023-12-28
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Vainauskas, Saulius
  • Chan, Siu-Hong
  • Taron, Christopher H.

Abrégé

The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures

7.

FCE MRNA CAPPING ENZYME COMPOSITIONS, METHODS AND KITS

      
Numéro d'application 18340083
Statut En instance
Date de dépôt 2023-06-23
Date de la première publication 2023-12-28
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. Brett

Abrégé

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

Classes IPC  ?

  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 9/10 - Transférases (2.)
  • A61K 39/245 - Herpetoviridae, p.ex. virus de l'Herpès simplex
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification

8.

Rapid Diagnostic Test for LAMP

      
Numéro d'application 18452104
Statut En instance
Date de dépôt 2023-08-18
Date de la première publication 2023-12-21
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta
  • Evans, Jr., Thomas C.

Abrégé

Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The compositions and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The compositions and methods are directed to labelled probes and their uses in Loop-Mediated Isothermal Amplification (LAMP) diagnostic tests to detect target DNA from the environment or from an individual and also to detect specific variants of the target DNA, both with similar sensitivity. The compositions and methods may use any single improvement or combination of improvements selected from thermolabile enzyme variants, poloxamers, various salts, indicators and one or more LAMP primer sets for detecting single and/or multiple targets, probes for detecting variants of the targets including SARS-CoV-2 variants and lateral flow devices.

Classes IPC  ?

  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
  • G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur

9.

METHODS AND COMPOSITIONS FOR THE SIMULTANEOUS IDENTIFICATION AND MAPPING OF DNA METHYLATION

      
Numéro d'application US2023068429
Numéro de publication 2023/245056
Statut Délivré - en vigueur
Date de dépôt 2023-06-14
Date de publication 2023-12-21
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Yan, Bo
  • Sun, Zhiyi
  • Vaisvila, Romualdas
  • Ettwiller, Laurence
  • Williams, Louise, Js
  • Ponnaluri, Chaithanya
  • Evanich, Daniel, J.
  • Panchapakesa, Vaishnavi

Abrégé

Provided herein is a method for generating a strand of DNA. In some embodiments, this method may comprise: (a) ligating a hairpin adaptor to a double-stranded fragment of DNA to produce a ligation product; (b) enzymatically generating a free 3' end in a double-stranded region of the hairpin adaptor in the ligation product; and (c) extending the free 3' end in a dCTP-free reaction mix that comprises a strand-displacing or nick-translating polymerase, dGTP, dATP, dTTP and modified dCTP to generate a hairpin product that has an original strand and a neosynthesized strand that contains modified Cs.

Classes IPC  ?

10.

RNase inhibitors

      
Numéro d'application 17207507
Numéro de brevet 11827885
Statut Délivré - en vigueur
Date de dépôt 2021-03-19
Date de la première publication 2023-11-28
Date d'octroi 2023-11-28
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Ong, Jennifer
  • Slayton, Esta
  • Maduzia, Lisa
  • Russello, Salvatore V.

Abrégé

Compositions, methods and kits are provided that include an inhibitory oligonucleotide RNase inhibitor capable of inhibiting one or more types of RNase that coexist with biological samples or are introduced in the laboratory, thereby protecting RNA in the sample from degradation. More than one type of oligonucleotide RNase inhibitor may be combined in a mixture to inhibit a plurality of different RNases. Single oligonucleotides were identified to have inhibitory activity for a plurality of different RNases. The RNase oligonucleotide inhibitor may be immobilized on beads or other surface. It may be stored in a lyophilized form or in solution.

Classes IPC  ?

  • C12N 15/11 - Fragments d'ADN ou d'ARN; Leurs formes modifiées
  • C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p.ex. oligonucléotides anti-sens
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12Q 1/6848 - Réactions d’amplification d’acides nucléiques caracterisées par les moyens d’empêcher la contamination ou d’augmenter la spécificité ou la sensibilité d’une réaction d’amplification
  • C12N 9/58 - Protéinases provenant de champignons

11.

Double-Stranded DNA Deaminases and Uses Thereof

      
Numéro d'application 18323143
Statut En instance
Date de dépôt 2023-05-24
Date de la première publication 2023-11-09
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Sun, Zhiyi
  • Johnson, Sean R.
  • Yan, Bo
  • Chen, Lixin
  • Robb, G. Brett
  • Evans, Jr., Thomas C.
  • Vaisvila, Romualdas

Abrégé

Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ ID NOS: 21, 40, 47, 49, 50, 55, 58, 59, 62, 63, 65, 67, 70, 71, 76, 106, 107, 110, 112, 114, 117, 163 and/or 164 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided.

Classes IPC  ?

  • C12Q 1/6869 - Méthodes de séquençage
  • C12N 9/02 - Oxydoréductases (1.), p.ex. luciférase
  • C12N 9/10 - Transférases (2.)
  • C12N 9/78 - Hydrolases (3.) agissant sur les liaisons carbone-azote autres que les liaisons peptidiques (3.5)

12.

LYOPRIME

      
Numéro d'application 230217000
Statut En instance
Date de dépôt 2023-11-06
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

(1) Reagents for scientific research use; reagents for molecular biology and/or cell biology for scientific, research, laboratory or in vitro diagnostic use; reagents for diagnostic tests and/or diagnostic devices for scientific, research, laboratory or in vitro diagnostic use; reagents for genetic research, clinical or medical laboratory use; enzyme reagents for scientific, research, laboratory or in vitro diagnostic use; enzymes for scientific and/or research use; enzymes for molecular biology research and/or cell biology scientific and research applications.

13.

METHODS OF HIGHER FIDELITY RNA SYNTHESIS

      
Numéro d'application US2023065496
Numéro de publication 2023/196950
Statut Délivré - en vigueur
Date de dépôt 2023-04-07
Date de publication 2023-10-12
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Roy, Bijoyita
  • Chen, Tien-Hao
  • Potapov, Vladimir
  • Ong, Jennifer
  • Dai, Nan

Abrégé

NN 1in vitroin vitro.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides

14.

COMPOSITIONS AND ANALYSIS OF DEPHOSPHORYLATED OLIGORIBONUCLEOTIDES

      
Numéro d'application US2023065602
Numéro de publication 2023/197015
Statut Délivré - en vigueur
Date de dépôt 2023-04-10
Date de publication 2023-10-12
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Correa, Ivan, R., Jr.
  • Wolf, Eric
  • Dai, Nan
  • Yigit, Erbay
  • Grünberg, Sebastian

Abrégé

Homo sapiens, Escherichia coli, Aspergillus oryzae, Momordica charanlia. Pyrococcus furiosus, Cucumis sativusSus scrojdSus scrojd) or (ii) is a non-naturally occurring sequence; and/or an RNA end repair enzyme having an amino acid sequence that (i) corresponds to an amino acid sequence of a species other than the first species (e.g., a bacterial species or a bacteriophage species) or (ii) is a non-naturally occurring sequence.

Classes IPC  ?

15.

Compositions and Analysis of Dephosphorylated Oligoribonucleotides

      
Numéro d'application 18298291
Statut En instance
Date de dépôt 2023-04-10
Date de la première publication 2023-09-14
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Correa, Jr., Ivan R.
  • Wolf, Eric
  • Dai, Nan
  • Yigit, Erbay
  • Grünberg, Sebastian

Abrégé

The present disclosure relates, according to some embodiments, to compositions and analysis of RNA (e.g., dephosphorylated oligoribonucleotides) including, for example, natural and/or synthetic RNAs. A composition may comprise, for example, an endoribonuclease having an amino acid sequence that (i) corresponds to an amino acid sequence of a first species (e.g., Homo sapiens, Escherichia coli, Aspergillus oryzae, Momordica charantia, Pyrococcus furiosus, Cucumis sativus, and Sus scrofa) or (ii) is a non-naturally occurring sequence; and/or an RNA end repair enzyme having an amino acid sequence that (i) corresponds to an amino acid sequence of a species other than the first species (e.g., a bacterial species or a bacteriophage species) or (ii) is a non-naturally occurring sequence.

Classes IPC  ?

  • C12Q 1/6872 - Méthodes de séquençage faisant intervenir la spectrométrie de masse

16.

IMMOBILIZED ENZYME COMPOSITIONS AND METHODS

      
Numéro d'application 18182122
Statut En instance
Date de dépôt 2023-03-10
Date de la première publication 2023-09-14
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Xu, Ming-Qun
  • García-Marquina, Guillermo
  • Chan, Siu-Hong
  • Correa, Jr., Ivan R.
  • Zhang, Aihua
  • Fang, Yi
  • Sproviero, Michael

Abrégé

The present disclosure relates, according to some embodiments, to immobilized enzyme compositions and methods for cleaving polynucleotide molecules including, for example, double-stranded DNA. Immobilized enzymes may comprise, for example, an enzyme (e.g., a type IIS restriction endonuclease, an RNAP, a capping enzyme), a support (e.g., a magnetic bead), and optionally, a linker disposed between the enzyme and the support. In some embodiments, methods may include contacting an immobilized enzyme with a polynucleotide substrate to form reaction products, separating the immobilized enzyme from the reaction products, and optionally reusing the immobilized enzymes in one or more subsequent reactions. preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase.

Classes IPC  ?

17.

TARGET ENRICHMENT

      
Numéro d'application US2023063895
Numéro de publication 2023/172934
Statut Délivré - en vigueur
Date de dépôt 2023-03-08
Date de publication 2023-09-14
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Hendrickson, Cynthia
  • Patel, Kruti

Abrégé

The present disclosure relates, according to some embodiments, to methods and compositions for preparing polynucleotide libraries enriched for a target sequence from source materials (e.g., samples comprising or constituting biological fluids, tissues, and/or specimens). Methods and compositions may provide efficient enrichment of the targeted polynucleotide. Enrichment may include increasing the relative abundance of the target from the source materials (where it may be present in low abundance) to the produced libraries (where it may be present in higher abundance). In some embodiments, methods include attaching (e.g., ligating, joining or otherwise fusing) an adapter to fragments of interest, nick translation, amplification (e.g., linear amplification), and target sequence selection using, for example, affinity tagging.

Classes IPC  ?

  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6816 - Tests d’hybridation caractérisés par les moyens de détection
  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6855 - Adaptateurs ligaturés

18.

IMMOBILIZED ENZYME COMPOSITIONS AND METHODS

      
Numéro d'application US2023064156
Numéro de publication 2023/173098
Statut Délivré - en vigueur
Date de dépôt 2023-03-10
Date de publication 2023-09-14
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Xu, Ming-Qun
  • Garcia-Marquina, Guillermo
  • Chan, Siu-Hong
  • Correa, Ivan R., Jr.
  • Zhang, Aihua
  • Fang, Yi
  • Sproviero, Michael

Abrégé

The present disclosure relates, according to some embodiments, to immobilized enzyme compositions and methods for cleaving polynucleotide molecules including, for example, double-stranded DNA. Immobilized enzymes may comprise, for example, an enzyme (e.g., a type IIS restriction endonuclease, an RNAP, a capping enzyme), a support (e.g., a magnetic bead), and optionally, a linker disposed between the enzyme and the support. In some embodiments, methods may include contacting an immobilized enzyme with a polynucleotide substrate to form reaction products, separating the immobilized enzyme from the reaction products, and optionally reusing the immobilized enzymes in one or more subsequent reactions, preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter- tagged fragments and, optionally, separated tailing enzyme and/or separated ligase.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 11/06 - Enzymes ou cellules microbiennes immobilisées sur ou dans un support organique attachées au support au moyen d'un agent de pontage
  • C12N 11/14 - Enzymes ou cellules microbiennes immobilisées sur ou dans un support inorganique
  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides
  • C12N 11/02 - Enzymes ou cellules microbiennes immobilisées sur ou dans un support organique
  • C12N 9/00 - Enzymes, p.ex. ligases (6.); Proenzymes; Compositions les contenant; Procédés pour préparer, activer, inhiber, séparer ou purifier des enzymes

19.

Double-Stranded DNA Deaminases

      
Numéro d'application 18058115
Statut En instance
Date de dépôt 2022-11-22
Date de la première publication 2023-08-17
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Vaisvila, Romualdas
  • Johnson, Sean R.
  • Sun, Zhiyi
  • Evans, Jr., Thomas C.

Abrégé

Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ ID NOS: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 19, 24, 26, 27, 28, 33, 40, 49, 50, 63, 95, 96, 97, and/or 99 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided.

Classes IPC  ?

  • C12N 9/78 - Hydrolases (3.) agissant sur les liaisons carbone-azote autres que les liaisons peptidiques (3.5)
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]

20.

Fragmentation of DNA

      
Numéro d'application 18305745
Statut En instance
Date de dépôt 2023-04-24
Date de la première publication 2023-08-17
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Apone, Lynne
  • Sexton, Brittany S.
  • Heider, Margaret
  • Williams, Louise Js
  • Dimalanta, Eileen T.

Abrégé

Provided herein is a polymerase-free enzyme mix (FRAG) for fragmenting double-stranded DNA. In some embodiments the enzyme mix may comprise a double-stranded DNA nickase and at least one of a DNA ligase capable of sealing a nick within a DNA, and a single-strand specific DNA nuclease. Methods for fragmenting double-stranded DNA are also provided.

Classes IPC  ?

  • C12Q 1/6869 - Méthodes de séquençage
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6855 - Adaptateurs ligaturés

21.

DOUBLE-STRANDED DNA DEAMINASES

      
Numéro d'application US2022080345
Numéro de publication 2023/097226
Statut Délivré - en vigueur
Date de dépôt 2022-11-22
Date de publication 2023-06-01
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Vaisvila, Romualdas
  • Johnson, Sean, R.
  • Sun, Zhiyi
  • Evans, Thomas, C.

Abrégé

Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ. ID NOS: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 19, 24, 26, 27, 28, 33, 40, 49, 50, 63, 95, 96, 97, and/or 99 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided.

Classes IPC  ?

22.

Isolation of High Molecular Weight DNA Using Beads

      
Numéro d'application 18155975
Statut En instance
Date de dépôt 2023-01-18
Date de la première publication 2023-05-18
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Koetsier, Paul A.
  • Taron, Barbara W.
  • Cantor, Eric J.

Abrégé

Provided herein is a method for isolating high molecular weight (HMW) DNA using beads that are at least 200 μm in diameter that utilizes a device for retaining the beads and where the purified DNA eluant exits the device without shearing the HMW DNA. In some embodiments, the method comprises precipitating the DNA onto the beads, washing the beads in the device, and then eluting the DNA from the beads therein while substantially avoiding shear. Compositions and kits for practicing the method are also provided.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • B01L 3/00 - Récipients ou ustensiles pour laboratoires, p.ex. verrerie de laboratoire; Compte-gouttes
  • B01L 9/06 - Supports de tubes à essai; Porte-tubes à essai

23.

MONARCH STABILYSE

      
Numéro de série 97936536
Statut En instance
Date de dépôt 2023-05-15
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques

Produits et services

Biological and biochemical reagents for scientific or medical research use; Biological and biochemical kits comprising enzymes and reagents for scientific or medical research use; Diagnostic reagents for clinical or medical laboratory use; Chemical products for commercial and scientific purposes, namely, chemicals or biochemicals for the stabilization, preservation, purification, modification, and manipulation of nucleic acids for scientific purposes and for use in polymerase chain reaction; Reagents for scientific and research use, for the stabilization, preservation, purification, modification, and manipulation of biologic samples, namely, nucleic acids (RNA and DNA); Reagents for scientific and research use, for the inactivation of infectious agents, namely, virus, bacteria, and parasites; Reagents for sample preparation, stabilization, preservation, purification, lysis, modification, and manipulation of cells and tissues Reagents for medical use in the stabilization of biologic samples, namely, nucleic acids (RNA and DNA); Reagents for medical use for the inactivation of infectious agents, namely, virus, bacteria, and parasites; Reagents for medical use for preparation, stabilization, preservation, purification, lysis, modification, and manipulation of cells and tissues Devices, namely, sample collection tubes for scientific and research use for the inactivation of infectious agents, namely, virus, bacteria, and parasites; Devices, namely, sample collection tubes for scientific and research use for the preparation, stabilization, preservation, purification, lysis, modification, and manipulation of cells and tissues; Devices, namely, sample collection tubes for scientific and research use, for the stabilization, preservation, purification, modification, and manipulation of biologic samples, namely, nucleic acids (RNA and DNA)

24.

Rolling Circle Reverse Transcription of Circular RNA

      
Numéro d'application 17820372
Statut En instance
Date de dépôt 2022-08-17
Date de la première publication 2023-05-11
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Guan, Shengxi
  • Maguire, Sean
  • Xu, Yan
  • Unlu, Irem

Abrégé

Compositions, methods and kits are provided that enable the detection, analysis and/or sequencing of small or large target RNA molecules whether synthetic, purified or within a biological fluid, or in cell lysate that may contain non-target RNA and other contaminating molecules without the need for depletion or purification steps that diminish what might already be low concentrations of the target molecule. The methods, compositions and kits rely on the use of a Group II Intron reverse transcriptase (Intron-RT) that have strand displacing properties and can generate concatemers in cDNA by rolling circle transcription of circRNAs that may be naturally circular or circularized in vitro from linear RNA.

Classes IPC  ?

  • C12Q 1/6848 - Réactions d’amplification d’acides nucléiques caracterisées par les moyens d’empêcher la contamination ou d’augmenter la spécificité ou la sensibilité d’une réaction d’amplification

25.

COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES

      
Numéro d'application US2022076778
Numéro de publication 2023/076772
Statut Délivré - en vigueur
Date de dépôt 2022-09-21
Date de publication 2023-05-04
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Correa, Ivan, R., Jr.
  • Zhang, Yinhua
  • Alpaslan, Ece

Abrégé

Provided herein is a composition comprising an enzyme that releases pyrophosphate from a substrate and a dye of Formula 1. A method for detecting pyrophosphate is also provided. A kit comprising a polymerase that releases pyrophosphate by hydrolysis of nucleoside triphosphates during nucleic acid replication, a divalent manganese salt, and the dye are also provided. The present composition, method and kits provide a way to detect and/or quantify substrates or products of enzyme reacted substrates associated with the release pyrophosphate (e.g., nucleic acid amplification reactions and other reactions that hydrolyze ATP) via a distinct color change without substantially affecting the sensitivity and/or specificity of the reaction.

Classes IPC  ?

  • G01N 33/52 - Utilisation de composés ou de compositions pour des recherches colorimétriques, spectrophotométriques ou fluorométriques, p.ex. utilisation de bandes de papier indicateur
  • C12Q 1/48 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir une transférase
  • C09B 29/036 - Colorants monoazoïques préparés par diazotation et copulation caractérisés par le composant diazo à partir d'amines diazotées contenant un hétérocycle l'hétérocycle ne contenant que de l'azote comme hétéro-atome
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • G01N 33/84 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des composés inorganiques ou le pH

26.

Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA

      
Numéro d'application 17907482
Statut En instance
Date de dépôt 2021-06-08
Date de la première publication 2023-04-20
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie

Abrégé

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

Classes IPC  ?

27.

Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA

      
Numéro d'application 17933943
Statut En instance
Date de dépôt 2022-09-21
Date de la première publication 2023-03-23
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie
  • Esteve, Pierre O.

Abrégé

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

Classes IPC  ?

  • C12Q 1/6869 - Méthodes de séquençage
  • C07K 14/31 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G)
  • C12N 9/22 - Ribonucléases

28.

INDURO

      
Numéro d'application 1716057
Statut Enregistrée
Date de dépôt 2023-02-01
Date d'enregistrement 2023-02-01
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; enzymes for scientific and research use; reagents for scientific and research use in the field of molecular biology; enzymes for scientific and research use in the field of molecular biology; kits comprising enzymes for scientific and research applications in the field of molecular biology.

29.

Rapid diagnostic test for lamp

      
Numéro d'application 17936084
Numéro de brevet 11732315
Statut Délivré - en vigueur
Date de dépôt 2022-09-28
Date de la première publication 2023-02-16
Date d'octroi 2023-08-22
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta
  • Evans, Jr., Thomas C.

Abrégé

Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The compositions and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The compositions and methods are directed to labelled probes and their uses in Loop-Mediated Isothermal Amplification (LAMP) diagnostic tests to detect target DNA from the environment or from an individual and also to detect specific variants of the target DNA, both with similar sensitivity. The compositions and methods may use any single improvement or combination of improvements selected from thermolabile enzyme variants, poloxamers, various salts, indicators and one or more LAMP primer sets for detecting single and/or multiple targets, probes for detecting variants of the targets including SARS-CoV-2 variants and lateral flow devices.

Classes IPC  ?

  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
  • G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur

30.

INDURO

      
Numéro d'application 224300300
Statut En instance
Date de dépôt 2023-02-01
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

(1) Reagents for scientific and research use; enzymes for scientific and research use; reagents for scientific and research use in the field of molecular biology; enzymes for scientific and research use in the field of molecular biology; kits comprising enzymes for scientific and research applications in the field of molecular biology.

31.

Methods for Labeling a Population of RNA Molecules

      
Numéro d'application 17932136
Statut En instance
Date de dépôt 2022-09-14
Date de la première publication 2023-01-26
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Schildkraut, Ira
  • Ettwiller, Laurence
  • Correa, Jr., Ivan R.
  • Tzertzinis, George
  • Buswell, John
  • Wulf, Madalee G.

Abrégé

A method of labeling, and optionally enriching, for a population of target RNA molecules in a mixture of RNAs is provided. In some embodiments, the method may comprise (a) adding a label to the 5′ end of 5′-diphosphorylated or 5′-triphosphorylated target RNA molecules in a sample by incubating the sample with labeled GTP and a capping enzyme; and (b) optionally enriching for target RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag. The label may be an oligonucleotide, which may further comprise an affinity group attached either internally or at 5′ or 3′ end of the oligonucleotide where the oligonucleotide label may be added directly, or indirectly via a reaction with a reactive group to the target RNA.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C07H 21/02 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p.ex. acides nucléiques avec le ribosyle comme radical saccharide
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]

32.

NEBNEXT ULTRAEXPRESS

      
Numéro de série 97767386
Statut En instance
Date de dépôt 2023-01-25
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, molecular biology and cell biology applications comprising enzymes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for genetic research, clinical or medical laboratory use; Kits for genetic research, nucleic acid sequencing, clinical or medical laboratory use comprising at least one of enzymes, buffers, cells and nucleic acids; Reagents for scientific and research use for use in sequencing nucleic acids; Kits for use in sequencing nucleic acids comprising at least one of enzymes, buffers, cells and nucleic acids

33.

High Throughput Reaction Assembly

      
Numéro d'application 17936144
Statut En instance
Date de dépôt 2022-09-28
Date de la première publication 2023-01-19
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ren, Guoping
  • Xu, Yan
  • Ma, Dong
  • Nichols, Nicole

Abrégé

Provided herein is a reverse transcriptase mixture comprising a reverse transcriptase and a colored dye at a concentration in the range of 0.003%-1% (v/w). The colored dye may be visually observed during transfer of the mix from one vessel to another and addition of the mix to another mix can be confirmed by eye by observing the colored dye.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12Q 1/48 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir une transférase
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6816 - Tests d’hybridation caractérisés par les moyens de détection
  • C12Q 1/6851 - Amplification quantitative
  • C12Q 1/686 - Réaction en chaine par polymérase [PCR]
  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques

34.

Vitro Cleavage of DNA Using Argonaute

      
Numéro d'application 17930079
Statut En instance
Date de dépôt 2022-09-07
Date de la première publication 2023-01-05
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Hunt, Eric

Abrégé

Methods, kits and compositions, in some embodiments, may include a thermostable DNA guided Argonaute protein for example TtAgo, a thermostable single-stranded DNA binding protein (SSB) for example, extreme thermostable single-stranded DNA binding protein (ET SSB), and, optionally, a strand-displacing polymerase. A SSB may allow (a) Argonaute/guide DNA complexes to substantially enhance cleavage efficiency of single- and double-stranded DNA substrates; (b) the use of longer guide DNAs (e.g., guide DNAs that are at least 24 nucleotides in length) and/or (c) increases in the sequence specificity of Argonaute-mediated binding and cleavage reactions.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C07K 14/195 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries
  • C12N 9/22 - Ribonucléases
  • C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p.ex. oligonucléotides anti-sens
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 15/90 - Introduction stable d'ADN étranger dans le chromosome
  • C12N 15/11 - Fragments d'ADN ou d'ARN; Leurs formes modifiées

35.

TARGET INITIATION AND AMPLIFICATION OF LONG DNA WITH NUCLEASE AND REPLISOME ENZYMES

      
Numéro d'application US2022032777
Numéro de publication 2022/261281
Statut Délivré - en vigueur
Date de dépôt 2022-06-09
Date de publication 2022-12-15
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Nye, Dillon, B.

Abrégé

in vitroin vitroin vitro linear amplification reaction enabling copying of at least 300 bases and as much as 50 kb of the target nucleic acid.

Classes IPC  ?

  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques

36.

AN ISOTHERMAL DIAGNOSTIC TEST THAT UTILIZES A CAS PROTEIN AND A POLYMERASE

      
Numéro d'application US2022032814
Numéro de publication 2022/261308
Statut Délivré - en vigueur
Date de dépôt 2022-06-09
Date de publication 2022-12-15
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Fuchs, Ryan, T.
  • Curcuru, Jennifer, L.
  • Robb, Brett, G.

Abrégé

Kits and methods are provided that utilize a mesophilic strand displacing polymerase selected from Bsu DNA polymerase (large fragment) and Klenow in Loop mediated amplification (LAMP) at temperatures in the range of 34°C-52°C. This contrasts with 60°C -65°C required for standard Bst polymerase dependent LAMP. The reduced temperature of the LAMP reaction enables the use of other proteins that are temperature sensitive in a one-step reaction. For example, a Cas protein such as Cas12a may be used with a target nucleic acid specific guide RNA and optionally a reporter oligonucleotide containing a quencher and a fluorophore or lateral flow reagents to determine the presence of pathogens in a sample.

Classes IPC  ?

37.

PROGRAMMABLE CLEAVAGE OF DOUBLE-STRANDED DNA

      
Numéro d'application US2022031288
Numéro de publication 2022/256247
Statut Délivré - en vigueur
Date de dépôt 2022-05-27
Date de publication 2022-12-08
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Bitinatie, Jurate
  • Vaiskunaite, Rita
  • Potapov, Vladimir
  • Tanner, Nathan

Abrégé

Clostridium butyricumClostridium butyricum) may be synchronized with DNA strand unwinding activity of a helicase (e.g., a nuclease deficient RecBexo- E.coli E.coli ) for a rapid and efficient cleavage of double-stranded DNA targets. Enzymatic properties of CbAgo and different aspects of ds DNA cleavage were thoroughly explored by adapting high-throughput capillary electrophoreses technique for monitoring CbAgo cleavage activity in concurrence with RecBexo-C. The present disclosure shows that in the presence of RecBexo-C., CbAgo can be programmed with guides to cleave any site of interest localized at up to 10 kb distance from the end of linear ds DNA at 37°C temperature. CbAgo /RecBexo-C. can be programmed to generate DNA fragments flanked with unique single- stranded extensions suitable for seamless ligation with compatible DNA fragments. The present disclosure relates further the compositions, methods, systems, and kits for PRC-free assembly of linear DNA molecules by using Cb Ago/RecBexo-C. programmable DNA endonuclease. The results presented here demonstrate that the combination of CbAgo and RecBexo-C. is currently an efficient mesophilic DNA-guided DNA-cleaving programmable endonuclease which can be used to prepare synthetic biology tools that require or benefit from sequence- specific nicking/cleavage of natural DNA at otherwise inaccessible locations.

Classes IPC  ?

  • C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac
  • C12N 9/22 - Ribonucléases
  • C12N 15/11 - Fragments d'ADN ou d'ARN; Leurs formes modifiées
  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides

38.

Programmable Cleavage of Double-Stranded DNA

      
Numéro d'application 17335500
Statut En instance
Date de dépôt 2021-06-01
Date de la première publication 2022-12-01
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Bitinaite, Jurate
  • Vaiskunaite, Rita
  • Potapov, Vladimir
  • Tanner, Nathan

Abrégé

The present disclosure relates, according to some embodiments, to compositions, methods, systems, and kits for programmable endonucleolytic cleavage of DNA (e.g., ds DNA). For example, the in vitro activity of an Argonaute (e.g., a mesophilic Argonaute CbAgo from Clostridium butyricum) may be synchronized with DNA strand unwinding activity of a helicase (e.g., a nuclease deficient RecBexo-C DNA helicase from E. coli) for a rapid and efficient cleavage of double-stranded DNA targets. Enzymatic properties of CbAgo and different aspects of ds DNA cleavage were thoroughly explored by adapting high-throughput capillary electrophoreses technique for monitoring CbAgo cleavage activity in concurrence with RecBexo-C. The present disclosure shows that in the presence of RecBexo-C, CbAgo can be programmed with guides to cleave any site of interest localized at up to 10 kb distance from the end of linear ds DNA at 37° C. temperature. CbAgo/RecBexo-C can be programmed to generate DNA fragments flanked with unique single-stranded extensions suitable for seamless ligation with compatible DNA fragments. The present disclosure relates further the compositions, methods, systems, and kits for PRC-free assembly of linear DNA molecules by using CbAgo/RecBexo-C programmable DNA endonuclease. The results presented here demonstrate that the combination of CbAgo and RecBexo-C is currently an efficient mesophilic DNA-guided DNA-cleaving programmable endonuclease which can be used to prepare synthetic biology tools that require or benefit from sequence-specific nicking/cleavage of natural DNA at otherwise inaccessible locations.

Classes IPC  ?

  • C12N 9/14 - Hydrolases (3.)
  • C07K 14/195 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries
  • C12N 15/11 - Fragments d'ADN ou d'ARN; Leurs formes modifiées
  • C12N 15/90 - Introduction stable d'ADN étranger dans le chromosome

39.

DNASE I VARIANTS, COMPOSITIONS, METHODS, AND KITS

      
Numéro d'application US2021034605
Numéro de publication 2022/250676
Statut Délivré - en vigueur
Date de dépôt 2021-05-27
Date de publication 2022-12-01
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Crosby, Heidi
  • Ong, Jennifer
  • Luck, Ashley
  • Cantor, Eric, J.
  • Potapov, Vladimir

Abrégé

The present disclosure relates, according to some embodiments, to systems, apparatus, compositions, methods, and workflows that include DNase I variants with desirable properties including, for example, salt tolerance. A DNase I variant, in some embodiments, may have an amino acid sequence that is at least 85% identical, at least 90% identical, at least 95% identical, and/or at least 98% identical to SEQ ID NO: 1 and may be identical to SEQ ID NO: 1 at one or more positions selected from the group of positions corresponding to L29, A35, D87, Q88, S94, P103, T108, P121, P132, A135, D145, E161, G172, P190, H208, and A224 of SEQ ID NO:1.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

40.

HISCRIBE

      
Numéro d'application 1699000
Statut Enregistrée
Date de dépôt 2022-11-03
Date d'enregistrement 2022-11-03
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; enzymes for scientific and research use; kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; reagents for scientific and research use in the field of molecular biology or cell biology applications; enzymes for scientific and research use in the field of molecular biology or cell biology applications; reagents for in vitro transcription for scientific and research use.

41.

DNase I Variants, Compositions, Methods, and Kits

      
Numéro d'application 17332821
Statut En instance
Date de dépôt 2021-05-27
Date de la première publication 2022-12-01
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Crosby, Heidi
  • Ong, Jennifer
  • Luck, Ashley
  • Cantor, Eric J.
  • Potapov, Vladimir

Abrégé

The present disclosure relates, according to some embodiments, to systems, apparatus, compositions, methods, and workflows that include DNase I variants with desirable properties including, for example, salt tolerance. A DNase I variant, in some embodiments, may have an amino acid sequence that is at least 85% identical, at least 90% identical, at least 95% identical, and/or at least 98% identical to SEQ ID NO:1 and may be identical to SEQ ID NO:1 at one or more positions selected from the group of positions corresponding to L29, A35, D87, Q88, S94, P103, T108, P121, P132, A135, D145, E161, G172, P190, H208, and A224 of SEQ ID NO:1.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C07K 14/47 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères

42.

Fragmentation of DNA

      
Numéro d'application 17658485
Numéro de brevet 11667968
Statut Délivré - en vigueur
Date de dépôt 2022-04-08
Date de la première publication 2022-12-01
Date d'octroi 2023-06-06
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Apone, Lynne
  • Sexton, Brittany S.
  • Heider, Margaret
  • Williams, Louise J S
  • Dimalanta, Eileen T.

Abrégé

Provided herein is a polymerase-free enzyme mix (FRAG) for fragmenting double-stranded DNA. In some embodiments the enzyme mix may comprise a double-stranded DNA nickase and at least one of a DNA ligase capable of sealing a nick within a DNA, and a single-strand specific DNA nuclease. Methods for fragmenting double-stranded DNA are also provided.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C40B 40/06 - Bibliothèques comprenant des nucléotides ou des polynucléotides ou leurs dérivés
  • C12Q 1/6869 - Méthodes de séquençage
  • C12Q 1/6855 - Adaptateurs ligaturés
  • C12Q 1/686 - Réaction en chaine par polymérase [PCR]
  • C40B 20/04 - Identification des éléments d'une bibliothèque au moyen d'une étiquette, d'un marqueur ou d'un autre identificateur lisible ou détectable, p.ex. procédés de décodage
  • C40B 50/06 - Procédés biochimiques, p.ex. utilisant des enzymes ou des micro-organismes viables entiers

43.

Compositions and methods for detecting pyrophosphate products of enzyme reactions using pyridylazoaniline dyes

      
Numéro d'application 17661954
Numéro de brevet 11512342
Statut Délivré - en vigueur
Date de dépôt 2022-05-04
Date de la première publication 2022-11-29
Date d'octroi 2022-11-29
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Correa, Jr., Ivan R.
  • Zhang, Yinhua
  • Alpaslan, Ece

Abrégé

Provided herein is a composition comprising an enzyme that releases pyrophosphate from a substrate and a dye of Formula 1. A method for detecting pyrophosphate is also provided. A kit comprising a polymerase that releases pyrophosphate by hydrolysis of nucleoside triphosphates during nucleic acid replication, a divalent manganese salt, and the dye are also provided. The present composition, method and kits provide a way to detect and/or quantify substrates or products of enzyme reacted substrates associated with the release pyrophosphate (e.g., nucleic acid amplification reactions and other reactions that hydrolyze ATP) via a distinct color change without substantially affecting the sensitivity and/or specificity of the reaction.

Classes IPC  ?

  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des acides nucléiques
  • C12Q 1/6816 - Tests d’hybridation caractérisés par les moyens de détection
  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques
  • C12Q 1/6876 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p.ex. amorces ou sondes

44.

HISCRIBE

      
Numéro d'application 222554700
Statut En instance
Date de dépôt 2022-11-03
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

(1) Reagents for scientific and research use; enzymes for scientific and research use; kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; reagents for scientific and research use in the field of molecular biology or cell biology applications; enzymes for scientific and research use in the field of molecular biology or cell biology applications; reagents for in vitro transcription for scientific and research use.

45.

Compositions and Methods Relating to Synthetic RNA Polynucleotides Created From Synthetic DNA Oligonucleotides

      
Numéro d'application 17846620
Statut En instance
Date de dépôt 2022-06-22
Date de la première publication 2022-10-20
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Robb, G. B.
  • Meek, Isaac B.
  • Schwarz, Dianne S.
  • Schildkraut, Ezra

Abrégé

Compositions and methods are provided for forming a single RNA polynucleotide from a plurality of DNA oligonucleotides in a single reaction chamber using combined reagents in a single step reaction. DNA polymerase, RNA polymerase and single stranded (ss) DNA oligonucleotides are combined where each DNA oligonucleotide has one or more sequence modules, wherein one sequence module in the first ss DNA oligonucleotide is complementary to a sequence module at the 3′ end of the second ss DNA oligonucleotide; and wherein a second module on the first ss DNA oligonucleotide is an RNA polymerase promoter sequence; and forming a single RNA polynucleotide, excluding the RNA promoter sequence, derived from the first and second DNA oligonucleotides

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides
  • C12N 9/22 - Ribonucléases
  • C12N 9/96 - Stabilisation d'une enzyme par formation d'un adduct ou d'une composition; Formation de conjugaisons d'enzymes
  • C12N 15/115 - Aptamères, c. à d. acides nucléiques liant spécifiquement une molécule cible avec une haute affinité sans s'y hybrider

46.

Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides

      
Numéro d'application 17825346
Statut En instance
Date de dépôt 2022-05-26
Date de la première publication 2022-09-29
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s) Gardner, Andrew F.

Abrégé

Provided herein, among other things, are various in vitro methods that involve cleaving dsDNA molecules that comprise a mismatched nucleotide using EndoMS. In some embodiments, the method may comprise ligating a T-tailed double-stranded adapter to A-tailed double-stranded fragments of nucleic acid to produce ligation products that comprise adapter-ligated fragments and double-stranded adapter dimers that comprise a T:T mismatch at the ligation junction and cleaving both strands of the adapter dimers using EndoMS.

Classes IPC  ?

  • C12Q 1/6855 - Adaptateurs ligaturés
  • C12N 9/22 - Ribonucléases
  • C12N 9/00 - Enzymes, p.ex. ligases (6.); Proenzymes; Compositions les contenant; Procédés pour préparer, activer, inhiber, séparer ou purifier des enzymes
  • C12Q 1/6874 - Méthodes de séquençage faisant intervenir des réseaux d’acides nucléiques, p.ex. séquençage par hybridation [SBH]

47.

Application of Immobilized Enzymes for Nanopore Library Construction

      
Numéro d'application 17828574
Statut En instance
Date de dépôt 2022-05-31
Date de la première publication 2022-09-22
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Xu, Ming-Qun
  • Fang, Yi
  • Zhang, Aihua
  • Sun, Luo

Abrégé

The present disclosure relates, according to some embodiments, to methods for preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase. In some embodiments, a tailing enzyme and/or a ligase used in library preparation may be immobilized enzymes.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6869 - Méthodes de séquençage

48.

Use of Thermostable RNA Polymerases to Produce RNAs Having Reduced Immunogenicity

      
Numéro d'application 17826946
Statut En instance
Date de dépôt 2022-05-27
Date de la première publication 2022-09-15
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Roy, Bijoyita
  • Robb, G. B.

Abrégé

Provided herein, among other things, is a method for producing an RNA product that has reduced immunogenicity. In some embodiments, the method involves transcribing a template DNA with a thermostable RNA polymerase at a temperature of greater than 44° C.

Classes IPC  ?

  • A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiques; Thérapie génique
  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides
  • A61K 31/713 - Acides nucléiques ou oligonucléotides à structure en double-hélice
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • A61K 31/7105 - Acides ribonucléiques naturels, c. à d. contenant uniquement des riboses liés à l'adénine, la guanine, la cytosine ou l'uracile et ayant des liaisons 3'-5' phosphodiester 
  • C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p.ex. oligonucléotides anti-sens

49.

Cleavage of Single Stranded DNA Having a Modified Nucleotide

      
Numéro d'application 17637430
Statut En instance
Date de dépôt 2020-08-21
Date de la première publication 2022-09-08
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Gardner, Andrew F.
  • Zatopek, Kelly M.

Abrégé

Methods are provided that, for example, include (a) combining ssDNA containing a modified nucleotide (e.g., a ssDNA with a modified nucleotide proximate to its 5′ end) with a DNA cleavage enzyme capable of cleaving the ssDNA at the modified nucleotide (e.g., to generate a first ssDNA fragment having a 3′OH and a second ssDNA fragment having the modified nucleotide); wherein the ratio of enzyme to DNA substrate is less than 1:1 molar ratio (m/m); and (b) cleaving at least 95% of the ssDNA at the modified nucleotide. In some embodiments, a method may comprise (a) combining (i) a ssDNA comprising a modified nucleotide (e.g., proximate to its 5′ end) with (ii) a DNA cleavage enzyme capable of cleaving the ssDNA at the modified nucleotide (e.g., to generate (after cleavage) a first ssDNA fragment having a 3′OH and a second ssDNA fragment comprising the modified nucleotide) wherein the ratio of enzyme to DNA substrate is less than 1:1 molar ratio and cleaving at least 95% of the ssDNA at the modified nucleotide. In some embodiments, methods provided herein may include (a) combining (i) a ssDNA (1) immobilized on a substrate and (2) comprising a modified nucleotide with (ii) a ssDNA cleaving enzyme capable of cleaving the ssDNA at the modified nucleotide (e.g., to generate (after cleavage) a first ssDNA fragment having a 3′OH and a second ssDNA fragment comprising the modified nucleotide) ; and (b) cleaving the immobilized ssDNA to release the second single stranded DNA fragment from the substrate. At least 95% (m/m) of an ssDNA comprising a modified nucleotide may be cleaved in less than 60 minutes.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12N 9/24 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2)
  • C07K 1/10 - Procédés généraux de préparation de peptides utilisant des agents de couplage

50.

Thermostable Variants of T7 RNA Polymerase

      
Numéro d'application 17742033
Statut En instance
Date de dépôt 2022-05-11
Date de la première publication 2022-09-01
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ong, Jennifer
  • Potapov, Vladimir
  • Hung, Kuo-Chan
  • Asahara, Haruichi
  • Chong, Shaorong
  • Tzertzinis, George

Abrégé

A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12Q 1/6858 - Amplification spécifique d’allèles

51.

COMPOSITIONS AND METHODS FOR LABELING MODIFIED NUCLEOTIDES IN NUCLEIC ACIDS

      
Numéro d'application US2022016743
Numéro de publication 2022/178093
Statut Délivré - en vigueur
Date de dépôt 2022-02-17
Date de publication 2022-08-25
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Ettwiller, Laurence
  • Weigele, Peter, R.
  • Yang, Weiwei
  • Lee, Yan-Jiun
  • Correa, Ivan, R.

Abrégé

Compositions, methods and kits are provided that describe a novel enzyme family called here a hydroxymethylcytosine carbamoyltransferase that transfers a carbamoyl phosphate substrate onto a hydroxymethylcytosine nucleoside triphosphate or a hydroxymethylcytosine in a nucleic acid. The carbamoyl phosphate substrate may be tagged with a chemically reactive group and optionally a functional group. This enables multiple uses of this enzyme and substrate for detecting nucleic acids with modified nucleotides, enriching for such nucleic acids, sequencing nucleic acids containing modified nucleotides, and for synthesizing oligonucleotides with various labels for various molecular biology applications including stabilizing RNA.

Classes IPC  ?

  • C12Q 1/48 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir une transférase
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6809 - Méthodes de détermination ou d’identification des acides nucléiques faisant intervenir la détection différentielle

52.

FAUSTOVIRUS CAPPING ENZYME, MRNA CAPPING ENZYME COMPOSITIONS, METHODS AND KITS

      
Numéro d'application US2021015320
Numéro de publication 2022/164428
Statut Délivré - en vigueur
Date de dépôt 2021-01-27
Date de publication 2022-08-04
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Chrispher, H.
  • Robb, G., Brett

Abrégé

e.g.,e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)

53.

FCE mRNA capping enzyme compositions, methods and kits

      
Numéro d'application 17377797
Numéro de brevet 11725196
Statut Délivré - en vigueur
Date de dépôt 2021-07-16
Date de la première publication 2022-07-28
Date d'octroi 2023-08-15
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. B.

Abrégé

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

Classes IPC  ?

  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)
  • A61K 39/245 - Herpetoviridae, p.ex. virus de l'Herpès simplex
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • C12N 9/10 - Transférases (2.)
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
  • C07K 14/005 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de virus

54.

Rapid diagnostic test for LAMP

      
Numéro d'application 17699950
Numéro de brevet 11525166
Statut Délivré - en vigueur
Date de dépôt 2022-03-21
Date de la première publication 2022-07-07
Date d'octroi 2022-12-13
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta

Abrégé

Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.

Classes IPC  ?

  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
  • G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur

55.

Methods and Enzymatic Compositions for Forming Libraries of Adapter Ligated Nucleic Acid Molecules

      
Numéro d'application 17594534
Statut En instance
Date de dépôt 2020-04-24
Date de la première publication 2022-07-07
Propriétaire New England Biolabs, Inc, (USA)
Inventeur(s)
  • Guan, Shengxi
  • Maguire, Sean

Abrégé

Compositions and methods of use are provided that among other things, allow for efficient adapter ligation to small RNAs. Embodiments of the compositions include partially double stranded polynucleotides for use as 3′ adapters that contain a cleavable linker positioned between a single-stranded region and a double-stranded region. Upon ligating the 3′ adapters, the single-stranded region is released by cleaving the cleavable linker.

Classes IPC  ?

  • C12Q 1/6855 - Adaptateurs ligaturés
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

56.

AUTHENTICASE

      
Numéro de série 97489697
Statut Enregistrée
Date de dépôt 2022-07-05
Date d'enregistrement 2023-12-19
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits comprised of enzymes for molecular biology and cell biology applications; Reagents for scientific and research use for molecular biology and cell biology applications; Enzymes for scientific and research use for molecular biology and cell biology applications; Reagents for scientific and research use for use in sequencing applications; Enzymes for scientific and research use for use in sequencing applications; Kits comprised of reagents and enzymes for use in sequencing applications for scientific use; Diagnostic reagents for clinical or medical laboratory use; Biological and biochemical reagents and kits comprised of biological and biochemical reagents for scientific or medical research use

57.

Chemical Capping for Template Switching

      
Numéro d'application 17610081
Statut En instance
Date de dépôt 2020-05-06
Date de la première publication 2022-06-23
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Correa, Jr., Ivan R.
  • Guan, Shengxi
  • Wulf, Madalee G.
  • Dai, Nan
  • Maguire, Sean

Abrégé

Provided herein is a method for chemically capping polynucleotides having a 5′ monophosphate. In some embodiments the method may comprise: combining an activated nucleoside 5′ mono- or poly-phosphate with a population of polynucleotides that comprises polynucleotides having a 5′ monophosphate, to produce a reaction mix; and incubating the reaction mix to produce reaction products that comprise a polynucleotide and a 5′ nucleoside cap, linked by a 5′ to 5′ polyphosphate linkage. The chemical capping method described herein can be incorporated into a variety of cDNA synthesis methods.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]

58.

IN VITRO ASSEMBLY OF POLYNUCLEOTIDES

      
Numéro d'application US2021010063
Numéro de publication 2022/132198
Statut Délivré - en vigueur
Date de dépôt 2021-12-15
Date de publication 2022-06-23
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Lohman, Gregory
  • Potapov, Vladimir
  • Pryor, John, M.
  • Kucera, Rebecca
  • Bilotti, Katharina
  • Morgan, Richard, D.

Abrégé

Ordered assembly of large numbers of fragments into a single large DN A have been improved in both frequency and fidelity of the assembled product. This has been achieved by novel compositions and methods that are utilized in a computer system that integrates comprehensive ligation data from multiple sources to provide optimized synthetic overhangs or overhangs from restriction endonuclease cleavage on DIMA fragments for assembly by ligation. Intragenic cut sites are avoided by the use of a novel restriction endonuclease which recognizes 7 nucleotides (bases) and cuts DNA to create 4-base overhangs with the help of a synthetic activator oligonucleotide. Variations in ligation preferences by different ligases provide extra precision in assembly reactions. The use of the improved methods are exemplified by the successful assembly from 52 fragments of a viral genome and also a 52 fragment ordered assembly of a bacteria operon.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12N 15/11 - Fragments d'ADN ou d'ARN; Leurs formes modifiées
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • G16B 25/20 - Réaction en chaîne par polymérase; Conception d’amorces ou de sondes; Optimisation de la sonde

59.

Compositions and Methods for Improved In Vitro Assembly of Polynucleotides

      
Numéro d'application 17644987
Statut En instance
Date de dépôt 2021-12-17
Date de la première publication 2022-06-09
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Lohman, Gregory
  • Potapov, Vladimir
  • Pryor, John M.
  • Kucera, Rebecca
  • Bilotti, Katharina
  • Morgan, Richard D.

Abrégé

Ordered assembly of large numbers of fragments into a single large DNA have been improved in both frequency and fidelity of the assembled product. This has been achieved by novel compositions and methods that are utilized in a computer system that integrates comprehensive ligation data from multiple sources to provide optimized synthetic overhangs or overhangs from restriction endonuclease cleavage on DNA fragments for assembly by ligation. Intragenic cut sites are avoided by the use of a novel restriction endonuclease which recognizes 7 nucleotides (bases) and cuts DNA to create 4-base overhangs with the help of a synthetic activator oligonucleotide. Variations in ligation preferences by different ligases provide extra precision in assembly reactions. The use of the improved methods are exemplified by the successful assembly from 52 fragments of a viral genome and also a 52 fragment ordered assembly of a bacteria operon.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/6855 - Adaptateurs ligaturés

60.

Ordered Assembly of Multiple DNA Fragments

      
Numéro d'application 17644516
Statut En instance
Date de dépôt 2021-12-15
Date de la première publication 2022-03-31
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Lohman, Gregory
  • Pryor, John M.
  • Kucera, Rebecca
  • Potapov, Vladimir
  • Bilotti, Katharina
  • Morgan, Richard D.

Abrégé

A composition and its uses and additionally a kit are provided. The composition is a synthetic self-complementary oligonucleotide that has a double-stranded region and a loop, wherein the double-stranded region contains a binding sequence for PaqCl. Additionally, the oligonucleotide includes unligatable 3′ and 5′ ends that cannot be cleaved by PaqCl. This oligonucleotide composition has been combined with PaqCl or a variant of PaqCl Type IIS restriction endonuclease in a reaction mixture, where the reaction mixture includes PaqCl or variant that can further be combined with a ligase and optionally a deadenylase, crowding molecule such as PEG and/or a repair enzyme such as Endo MS. The kit includes the oligonucleotide and Type IIS restriction endonuclease in the same or different containers.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6869 - Méthodes de séquençage

61.

Application of immobilized enzymes for nanopore library construction

      
Numéro d'application 17018862
Numéro de brevet 11377654
Statut Délivré - en vigueur
Date de dépôt 2020-09-11
Date de la première publication 2022-03-24
Date d'octroi 2022-07-05
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Xu, Ming-Qun
  • Fang, Yi
  • Zhang, Aihua
  • Sun, Luo

Abrégé

The present disclosure relates, according to some embodiments, to methods for preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase. In some embodiments, a tailing enzyme and/or a ligase used in library preparation may be immobilized enzymes.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6869 - Méthodes de séquençage

62.

NEBINSPIRED

      
Numéro de série 97316669
Statut Enregistrée
Date de dépôt 2022-03-17
Date d'enregistrement 2023-04-04
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 41 - Éducation, divertissements, activités sportives et culturelles

Produits et services

On-line journals, namely, blogs featuring topics on science, art, lab tips, environmental sustainability, career advice and social responsibility; Providing a website featuring blogs and non-downloadable publications in the nature of articles in the field(s) of life sciences

63.

APPLICATION OF IMMOBILIZED ENZYMES FOR NANOPORE LIBRARY CONSTRUCTION

      
Numéro d'application US2020050520
Numéro de publication 2022/055500
Statut Délivré - en vigueur
Date de dépôt 2020-09-11
Date de publication 2022-03-17
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Xu, Ming-Qun
  • Fang, Yi
  • Zhang, Aihua
  • Sun, Luo

Abrégé

The present disclosure relates, according to some embodiments, to methods for preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter- tagged fragments; and/or separating adapter- tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase. In some embodiments, a tailing enzyme and/or a ligase used in library preparation may be immobilized enzymes.

Classes IPC  ?

  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6869 - Méthodes de séquençage

64.

Analysis of chromatin using a nicking enzyme

      
Numéro d'application 17454082
Numéro de brevet 11840741
Statut Délivré - en vigueur
Date de dépôt 2021-11-09
Date de la première publication 2022-02-24
Date d'octroi 2023-12-12
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ponnaluri, Chaithanya
  • Chin, Hang-Gyeong
  • Esteve, Pierre O.
  • Pradhan, Sriharsa

Abrégé

Provided herein, among other things, are various compositions and methods for analyzing chromatin. In some embodiments, the composition may comprise a mixture of a nicking enzyme, four dNTPs, at least one labeled dNTP and, optionally, a polymerase. In some embodiments, this method may comprise: obtaining a sample comprising chromatin, reacting the sample with the composition to selectively label the open chromatin in the sample, and analyzing the labeled sample.

Classes IPC  ?

  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des acides nucléiques
  • C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p.ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6841 - Hybridation in situ
  • C12Q 1/6869 - Méthodes de séquençage
  • C12Q 1/6827 - Tests d’hybridation pour la détection de mutation ou de polymorphisme

65.

A RAPID DIAGNOSTIC TEST FOR LAMP

      
Numéro d'application US2021046730
Numéro de publication 2022/040443
Statut Délivré - en vigueur
Date de dépôt 2021-08-19
Date de publication 2022-02-24
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine, B.
  • Strimpel, Harriet, M.
  • Correa, Ivan, R., Jr.
  • Carlow, Clotilde
  • Slayton, Esta

Abrégé

Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.

Classes IPC  ?

  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages

66.

NEBNEXT ULTRASHEAR

      
Numéro de série 97278155
Statut Enregistrée
Date de dépôt 2022-02-22
Date d'enregistrement 2023-12-19
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, molecular biology and cell biology applications comprising enzymes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for genetic research, clinical or medical laboratory use; Kits for genetic research, nucleic acid sequencing, clinical or medical laboratory use comprising at least one of enzymes, buffers, cells and nucleic acids; Reagents for scientific and research use for use in sequencing nucleic acids; Kits for use in sequencing nucleic acids comprising at least one of enzymes, buffers, cells and nucleic acids

67.

NEBRIDGE LIGASE FIDELITY VIEWER

      
Numéro de série 97242105
Statut Enregistrée
Date de dépôt 2022-01-27
Date d'enregistrement 2023-07-11
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

68.

NEBRIDGE GETSET

      
Numéro de série 97242111
Statut Enregistrée
Date de dépôt 2022-01-27
Date d'enregistrement 2023-04-18
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

69.

NEBRIDGE

      
Numéro de série 97242088
Statut Enregistrée
Date de dépôt 2022-01-27
Date d'enregistrement 2023-07-11
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

70.

NEBRIDGE SPLITSET

      
Numéro de série 97242115
Statut Enregistrée
Date de dépôt 2022-01-27
Date d'enregistrement 2023-04-18
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

71.

HISCRIBE HI-T7

      
Numéro de série 97219453
Statut Enregistrée
Date de dépôt 2022-01-14
Date d'enregistrement 2024-04-02
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; Reagents for scientific and research use in the field of molecular biology or cell biology applications; Enzymes for scientific and research use in the field of molecular biology or cell biology applications; Reagents for in vitro transcription for scientific and research use

72.

Rapid diagnostic test for LAMP

      
Numéro d'application 17406959
Numéro de brevet 11345970
Statut Délivré - en vigueur
Date de dépôt 2021-08-19
Date de la première publication 2021-12-30
Date d'octroi 2022-05-31
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta

Abrégé

Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.

Classes IPC  ?

  • G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages

73.

Vaccinia capping enzyme compositions and methods

      
Numéro d'application 17348127
Numéro de brevet 11788074
Statut Délivré - en vigueur
Date de dépôt 2021-06-15
Date de la première publication 2021-12-23
Date d'octroi 2023-10-17
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Vainauskas, Saulius
  • Chan, Siu-Hong
  • Taron, Christopher H.

Abrégé

The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
  • C12R 1/84 - Pichia

74.

Compositions and methods for detecting molecular targets on chromosomal DNA

      
Numéro d'application 17342216
Numéro de brevet 11492667
Statut Délivré - en vigueur
Date de dépôt 2021-06-08
Date de la première publication 2021-12-16
Date d'octroi 2022-11-08
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie
  • Esteve, Pierre O.

Abrégé

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

Classes IPC  ?

  • C12Q 1/6869 - Méthodes de séquençage
  • C07K 14/31 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G)
  • C12N 9/22 - Ribonucléases

75.

COMPOSITIONS AND METHODS FOR DETECTING MOLECULAR TARGETS ON CHROMOSOMAL DNA

      
Numéro d'application US2021036414
Numéro de publication 2021/252498
Statut Délivré - en vigueur
Date de dépôt 2021-06-08
Date de publication 2021-12-16
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie
  • Esteve, Pierre Olivier

Abrégé

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

Classes IPC  ?

76.

Compositions and Methods for Analyzing Modified Nucleotides

      
Numéro d'application 17445286
Statut En instance
Date de dépôt 2021-08-17
Date de la première publication 2021-12-16
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Vaisvila, Romualdas
  • Sun, Zhiyi
  • Guan, Shengxi
  • Saleh, Lana
  • Ettwiller, Laurence
  • Davis, Theodore B.

Abrégé

A method for identifying any of the presence, location and phasing of modified cytosines (C) in long stretches of nucleic acids is provided. In some embodiments, the method may comprise (a) reacting a first portion of a nucleic acid sample containing at least one C and/or at least one modified C with a DNA glucosyltransferase and a cytidine deaminase to produce a first product and/or reacting a second portion of the sample with a dioxygenase, optionally a DNA glucosyltransferase and a cytidine deaminase to produce a second product and; (b) comparing the sequences from the first and optionally the second product obtained in (a), or amplification products thereof, with each other and/or an untreated reference sequence to determine which Cs in the initial nucleic acid fragment are modified. A modified TET methylcytosine dioxygenase with improved efficiency compared to unmodified TET2 at converting methylcytosine to carboxymethylcytosine is also provided.

Classes IPC  ?

  • C12Q 1/6858 - Amplification spécifique d’allèles
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6827 - Tests d’hybridation pour la détection de mutation ou de polymorphisme
  • C12N 9/02 - Oxydoréductases (1.), p.ex. luciférase
  • C12Q 1/6869 - Méthodes de séquençage
  • C12Q 1/6872 - Méthodes de séquençage faisant intervenir la spectrométrie de masse

77.

Improved Ordered Assembly of Multiple DNA Fragments

      
Numéro d'application 17286066
Statut En instance
Date de dépôt 2019-10-17
Date de la première publication 2021-12-09
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Lohman, Gregory
  • Potapov, Vladimir
  • Pryor, John M.
  • Kucera, Rebecca

Abrégé

Methods and compositions are provided for optimizing ordered assembly of a plurality of polynucleotide fragments. The optimization involves providing sets of overhang sequences with preferred experimental conditions for high fidelity ordered assembly of polynucleotide fragments by ligation under selected experimental conditions. The methods and compositions provide the use of a computer system with inputs having a plurality of menus and outputs that include a variety of media interfaces. The computer system has access to a ligation frequency database to provide sets of overhang sequences for efficient joining of multiple fragments into the target nucleic acid. In-puts include one or more of the following: numbers and sizes of fragments, optionally a desired target polynucleotide sequence from a database, in which case one output are the recommended polynucleotide fragments for ordered assembly, and selected experimental conditions selected from any or all of ligation protocols and ligation temperature with reaction times, salt concentration in the ligation buffer, choice of ligase and restriction endonuclease and the use of DNA repair enzymes.

Classes IPC  ?

  • G16B 30/20 - Assemblage de séquences
  • C12N 15/66 - Méthodes générales pour insérer un gène dans un vecteur pour former un vecteur recombinant, utilisant le clivage et la ligature; Utilisation de linkers non fonctionnels ou d'adaptateurs, p.ex. linkers contenant la séquence pour une endonucléase de restriction
  • G16B 50/30 - Entreposage de données; Architectures informatiques

78.

BST 2.0 WARMSTART

      
Numéro de série 97159916
Statut En instance
Date de dépôt 2021-12-07
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Enzymes for scientific and research use in the field of molecular biology and cell biology applications

79.

BST 2.0

      
Numéro de série 97063615
Statut En instance
Date de dépôt 2021-10-07
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Enzymes for scientific and research use in the field of molecular biology and cell biology applications

80.

BST 2.0

      
Numéro d'application 018572500
Statut Enregistrée
Date de dépôt 2021-10-06
Date d'enregistrement 2022-02-22
Propriétaire New England BioLabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Enzymes for scientific and research use in the field of molecular biology and cell biology applications.

81.

Method for fragmenting DNA by nick translation

      
Numéro d'application 17243707
Numéro de brevet 11802304
Statut Délivré - en vigueur
Date de dépôt 2021-04-29
Date de la première publication 2021-09-23
Date d'octroi 2023-10-31
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Guan, Chudi
  • Yan, Bo

Abrégé

Providing herein, among other things, are kits, compositions and methods that relate to DNA fragmentation. An embodiment of a composition provides combining: one or more enzymes capable of nick translating activity, a dNTP mix comprising at least one dNTP having a modified base, and at least one modification-sensitive nicking endonuclease that is prevented from nicking DNA if its recognition site contains the modified base. When the composition is added to a sample comprising a double-stranded DNA template that comprises recognition sites for the modification-sensitive nicking endonuclease, a reaction mix was produced which could be incubated for any time period in excess of about 5 minutes to produce fragments of a desired size of the double-stranded DNA template. In this method, the fragments produced include the modified base and, as such, are not re-nicked by the nicking endonuclease.

Classes IPC  ?

  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12Q 1/6855 - Adaptateurs ligaturés
  • C12N 15/66 - Méthodes générales pour insérer un gène dans un vecteur pour former un vecteur recombinant, utilisant le clivage et la ligature; Utilisation de linkers non fonctionnels ou d'adaptateurs, p.ex. linkers contenant la séquence pour une endonucléase de restriction
  • C12N 9/22 - Ribonucléases

82.

Rapid diagnostic test using colorimetric lamp

      
Numéro d'application 17178395
Numéro de brevet 11492673
Statut Délivré - en vigueur
Date de dépôt 2021-02-18
Date de la première publication 2021-09-16
Date d'octroi 2022-11-08
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Nichols, Nicole

Abrégé

Kits and methods are provided for performing multiplex LAMP reactions. These kits and methods are directed to specific and sensitive methods of target nucleic acid detection and more specifically pathogen diagnostics such as detection of Coronavirus. The kits and methods utilize a plurality of sets of oligonucleotide primers for targeting the viral nucleic acid target.

Classes IPC  ?

  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
  • G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques

83.

Rapid diagnostic test using colorimetric LAMP

      
Numéro d'application 17221451
Numéro de brevet 11155887
Statut Délivré - en vigueur
Date de dépôt 2021-04-02
Date de la première publication 2021-09-16
Date d'octroi 2021-10-26
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Nichols, Nicole

Abrégé

Kits and methods are provided for performing multiplex Loop-Mediated Isothermal Amplification (LAMP) reactions. These kits and methods are directed to specific and sensitive methods of target nucleic acid detection and more specifically pathogen diagnostics such as detection of Coronavirus. The kits and methods utilize a plurality of sets of oligonucleotide primers for targeting the viral nucleic acid target.

Classes IPC  ?

  • G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages

84.

A RAPID DIAGNOSTIC TEST FOR LAMP

      
Numéro d'application US2021022160
Numéro de publication 2021/183921
Statut Délivré - en vigueur
Date de dépôt 2021-03-12
Date de publication 2021-09-16
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine, B.
  • Strimpel, Harriet, M.
  • Correa, Ivan, R., Jr.

Abrégé

Kits and Methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and multiple Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets in a single reaction.

Classes IPC  ?

  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages

85.

LYOPRIME LUNA

      
Numéro de série 97024139
Statut Enregistrée
Date de dépôt 2021-09-13
Date d'enregistrement 2023-04-11
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific research use; reagents for molecular biology and/or cell biology for scientific, research, laboratory or in vitro diagnostic use; reagents for diagnostic tests and/or diagnostic devices for scientific, research, laboratory or in vitro diagnostic use; reagents for genetic research, clinical or medical laboratory use; enzyme reagents for scientific, research, laboratory or in vitro diagnostic use; enzymes for scientific and/or research use; enzymes for molecular biology research and/or cell biology scientific and research applications

86.

FCE mRNA capping enzyme compositions, methods and kits

      
Numéro d'application 17246454
Numéro de brevet 11098295
Statut Délivré - en vigueur
Date de dépôt 2021-04-30
Date de la première publication 2021-08-24
Date d'octroi 2021-08-24
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. B.

Abrégé

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

Classes IPC  ?

  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • C12N 9/10 - Transférases (2.)
  • A61K 39/245 - Herpetoviridae, p.ex. virus de l'Herpès simplex
  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps

87.

VARIANT FAMILY D DNA POLYMERASES

      
Numéro d'application US2021017956
Numéro de publication 2021/163561
Statut Délivré - en vigueur
Date de dépôt 2021-02-12
Date de publication 2021-08-19
Propriétaire NEW ENGLAND BIOLABS, INC. (USA)
Inventeur(s)
  • Gardner, Andrew, F.
  • Zatopek, Kelly, M.
  • Evans, Thomas, C.
  • Alpaslan, Ece

Abrégé

The present disclosure relates to polymerases (e.g., variants of Family D DNA polymerases) for polynucleotide synthesis, polynucleotide amplification, polynucleotide sequencing, cloning a polynucleotide, or combinations thereof. Variant Family D polymerases have one or more substitutions relative to wild type Family D polymerases (e.g., substitutions impacting substrate selectivity) and may incorporate ribonucleotides and/or modified nucleotides into synthesized or extended strands.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)

88.

VARIANT FAMILY D DNA POLYMERASES

      
Numéro d'application US2021017954
Numéro de publication 2021/163559
Statut Délivré - en vigueur
Date de dépôt 2021-02-12
Date de publication 2021-08-19
Propriétaire
  • NEW ENGLAND BIOLABS, INC. (USA)
  • INSTITUT PASTEUR (France)
Inventeur(s)
  • Gardner, Andrew, F.
  • Zatopek, Kelly, M.
  • Evans, Thomas, C.
  • Alpaslan, Ece
  • Sauguet, Ludovic

Abrégé

The present disclosure relates to polymerases (e.g., variants of Family D DNA polymerases) for polynucleotide synthesis, polynucleotide amplification, polynucleotide sequencing, cloning a polynucleotide, or combinations thereof. For example, a variant Family D polymerase may have an amino acid sequence that (a) is at least 99%, identical to SEQ ID NO:1 and (b) has a substitution at a position selected from positions corresponding to positions 106-161, 243-267, 326-330, 361-365, 385-397, 441-451, 657-667, 822-829, 919-928, and 940-962, 981-997 of SEQ ID NO:1.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)

89.

HISCRIBE

      
Numéro de série 90885013
Statut Enregistrée
Date de dépôt 2021-08-16
Date d'enregistrement 2022-09-13
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Reagents for scientific and research use; enzymes for scientific and research use; kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; reagents for scientific and research use in the field of molecular biology or cell biology applications; enzymes for scientific and research use in the field of molecular biology or cell biology applications; reagents for in vitro transcription for scientific and research use

90.

NEAT-SEQ

      
Numéro de série 90879289
Statut En instance
Date de dépôt 2021-08-12
Propriétaire New England Biolabs, Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Reagents and reagent kits comprising enzymes, labels, buffers, DNA binding molecules or antibodies for the purpose of analyzing chromosomal DNA, DNA structure, nucleotide sequence variants or nucleotide modifications in or from in vitro or in the biological compartments or chromosomal DNA that are normal or abnormal, in the fields of scientific, diagnostic and clinical research Computer hardware and recorded computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; scientific apparatus and instruments, namely, nucleic acid sequencers for laboratory use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics Custom design and/or data analysis of assays for scientific and research purposes for location of DNA binding proteins in in vitro samples, biological compartments or on chromosomal DNA; Custom design and/or data analysis of assays for identifying nucleotide variants and modifications in vitro or in biological compartments or chromosomal DNA; Custom design and/or data analysis of assays for determining DNA structure; Providing online, non-downloadable software tools for sequencing, mapping, recording or archiving located nucleic sequences associated with DNA binding proteins, DNA structure, nucleotide variants or modifications from in vitro samples, biological compartments or on chromosomal DNA

91.

High Fidelity Restriction Endonucleases

      
Numéro d'application 17226693
Statut En instance
Date de dépôt 2021-04-09
Date de la première publication 2021-08-05
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Zhu, Zhenyu
  • Quimby, Aine
  • Guan, Shengxi
  • Sun, Dapeng
  • Huang, Yishu
  • Lai, Xuhui
  • Chan, Siu-Hong
  • Li, Xianghui
  • Xu, Shuang-Yong
  • Zhang, Chunhua

Abrégé

Methods and compositions are provided for engineering mutant enzymes with reduced star activity where the mutant enzymes have a fidelity index (FI) in a specified buffer that is greater than the FI of the non-mutated enzyme in the same buffer.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C12Q 1/34 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir une hydrolase
  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)
  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des acides nucléiques
  • C12Q 1/44 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir une hydrolase une estérase

92.

High Fidelity Restriction Endonucleases

      
Numéro d'application 17227799
Statut En instance
Date de dépôt 2021-04-12
Date de la première publication 2021-07-29
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Zhu, Zhenyu
  • Quimby, Aine
  • Xu, Shuang-Yong
  • Guan, Shengxi
  • Wei, Hua
  • Zhang, Penghua
  • Sun, Dapeng
  • Chan, Siu-Hong

Abrégé

Compositions and methods are provided for enzymes with altered properties that involve a systematic approach to mutagenesis and a screening assay that permits selection of the desired proteins. Embodiments of the method are particularly suited for modifying specific properties of restriction endonucleases such as star activity. The compositions includes restriction endonucleases with reduced star activity as defined by an overall fidelity index improvement factor.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12N 9/22 - Ribonucléases
  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)

93.

PAQCI

      
Numéro d'application 1602659
Statut Enregistrée
Date de dépôt 2021-05-20
Date d'enregistrement 2021-05-20
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Enzymes for scientific and research use; kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; enzymes for scientific and research use in the field of molecular biology and cell biology applications.

94.

Compositions and methods for analyzing modified nucleotides

      
Numéro d'application 17181351
Numéro de brevet 11939628
Statut Délivré - en vigueur
Date de dépôt 2021-02-22
Date de la première publication 2021-07-08
Date d'octroi 2024-03-26
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Vaisvila, Romualdas
  • Davis, Theodore B.
  • Guan, Shengxi
  • Sun, Zhiyi
  • Ettwiller, Laurence
  • Saleh, Lana

Abrégé

5hmC in a DNA.

Classes IPC  ?

  • C12Q 1/6827 - Tests d’hybridation pour la détection de mutation ou de polymorphisme
  • C12N 9/02 - Oxydoréductases (1.), p.ex. luciférase
  • C12N 9/78 - Hydrolases (3.) agissant sur les liaisons carbone-azote autres que les liaisons peptidiques (3.5)
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p.ex. pour test de réaction en chaîne par polymérase [PCR]

95.

FCE mRNA capping enzyme compositions, methods and kits

      
Numéro d'application 17160256
Numéro de brevet 11028379
Statut Délivré - en vigueur
Date de dépôt 2021-01-27
Date de la première publication 2021-06-08
Date d'octroi 2021-06-08
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. B.

Abrégé

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

Classes IPC  ?

  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 9/10 - Transférases (2.)
  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
  • A61K 39/245 - Herpetoviridae, p.ex. virus de l'Herpès simplex

96.

Method for removing and/or detecting nucleic acids having mismatched nucleotides

      
Numéro d'application 16616631
Numéro de brevet 11371088
Statut Délivré - en vigueur
Date de dépôt 2018-06-11
Date de la première publication 2021-06-03
Date d'octroi 2022-06-28
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s) Gardner, Andrew F.

Abrégé

Provided herein, among other things, are various in vitro methods that involve cleaving dsDNA molecules that comprise a mismatched nucleotide using EndoMS. In some embodiments, the method may comprise ligating a T-tailed double-stranded adapter to A-tailed double-stranded fragments of nucleic acid to produce ligation products that comprise adapter-ligated fragments and double-stranded adapter dimers that comprise a T:T mismatch at the ligation junction and cleaving both strands of the adapter dimers using EndoMS.

Classes IPC  ?

  • C12Q 1/6855 - Adaptateurs ligaturés
  • C12N 9/22 - Ribonucléases
  • C12N 9/00 - Enzymes, p.ex. ligases (6.); Proenzymes; Compositions les contenant; Procédés pour préparer, activer, inhiber, séparer ou purifier des enzymes
  • C12Q 1/6874 - Méthodes de séquençage faisant intervenir des réseaux d’acides nucléiques, p.ex. séquençage par hybridation [SBH]

97.

Variant DNA polymerases having improved properties and method for improved isothermal amplification of a target DNA

      
Numéro d'application 17156704
Numéro de brevet 11371028
Statut Délivré - en vigueur
Date de dépôt 2021-01-25
Date de la première publication 2021-05-27
Date d'octroi 2022-06-28
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Ong, Jennifer
  • Tanner, Nathan
  • Zhang, Yinhua
  • Bei, Yanxia
  • Potapov, Vladimir

Abrégé

Variants of the bacteriophage B103 DNA polymerase are described herein. The variant has improved properties, that include when compared to wild-type Phi29 DNA polymerase, at least one of the following: increased thermostability, improved reaction rate for DNA amplification, reduced background and a reduction of bias. Methods of using the DNA polymerase variant are also described herein.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification

98.

PAQCI

      
Numéro d'application 212098400
Statut Enregistrée
Date de dépôt 2021-05-20
Date d'enregistrement 2023-11-08
Propriétaire New England Biolabs, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

(1) Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; enzymes for scientific and research use in the field of molecular biology and cell biology applications

99.

Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity

      
Numéro d'application 16616734
Numéro de brevet 11376338
Statut Délivré - en vigueur
Date de dépôt 2018-06-12
Date de la première publication 2021-05-20
Date d'octroi 2022-07-05
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Roy, Bijoyita
  • Robb, G. B.

Abrégé

Provided herein, among other things, is a method for producing an RNA product that has reduced immunogenicity. In some embodiments, the method involves transcribing a template DNA with a thermostable RNA polymerase at a temperature of greater than 44° C.

Classes IPC  ?

  • A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiques; Thérapie génique
  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides
  • A61K 31/713 - Acides nucléiques ou oligonucléotides à structure en double-hélice
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p.ex. kinases (2.7)
  • A61K 31/7105 - Acides ribonucléiques naturels, c. à d. contenant uniquement des riboses liés à l'adénine, la guanine, la cytosine ou l'uracile et ayant des liaisons 3'-5' phosphodiester 
  • C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p.ex. oligonucléotides anti-sens

100.

Rapid diagnostic test using colorimetric LAMP

      
Numéro d'application 17122979
Numéro de brevet 11008629
Statut Délivré - en vigueur
Date de dépôt 2020-12-15
Date de la première publication 2021-05-18
Date d'octroi 2021-05-18
Propriétaire New England Biolabs, Inc. (USA)
Inventeur(s)
  • Tanner, Nathan
  • Zhang, Yinhua
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Nichols, Nicole

Abrégé

Kits and methods are provided for performing multiplex LAMP reactions. These kits and methods are directed to specific and sensitive methods of target nucleic acid detection and more specifically pathogen diagnostics such as detection of Coronavirus. The kits and methods utilize a plurality of sets of oligonucleotide primers for targeting the viral nucleic acid target.

Classes IPC  ?

  • G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
  1     2     3     ...     5        Prochaine page